FTSE ST Small Cap Index’s 5 Best-Performing Constituents Avg 36% YTD Return | SGX My Gateway

(Source: sginvestors.io)

SGX Market Updates

BY |



PUBLISHED ON |

12 July 2018

12 July 2018

  • The FTSE ST Small Cap Index comprises 65 constituents that average a market cap of S$750 million, ranging from S$103 million to S$2.6 billion. Beyond the Index are nearly 200 stocks listed on SGX that fall within this market cap range.

  • The 10 largest constituents of the FTSE ST Small Cap Index account for about 40% of index weight, and represent the Real Estate sector. Nine of them are REITs, while one is a real estate developer. Given the significant Real Estate weighting, the Index maintains a relatively high dividend yield of 3.8%, almost on par with the STI’s 4.0% yield.

  • In the YTD, the five best-performing Index constituents were: China Sunsine Chemical (+69.4%), BreadTalk (+40.9%), Japfa (+27.8%), Tianjin Zhongxin Pharma (+20.1%), and HRnetGroup (+19.1%). These five stocks averaged a +35.5% total return in the YTD, bringing their average 12-month total return to +28.6%.

The FTSE ST Small Cap Index is a free float-adjusted, market capitalisation-weighted index. It represents the performance of small-capitalised companies, which pass size, free float and liquidity screens, and trade on SGX Mainboard.

The FTSE ST Small Cap Index comprises 65 constituents with an average market capitalisation of S$750 million, and that range extends from S$103 million to S$2.6 billion. More broadly, beyond the Index are nearly 200 stocks listed on SGX that fall within this market capitalisation range.

The 10 largest constituents of the FTSE ST Small Cap Index account for about 40% of index weight, and represent the Real Estate sector. Nine of these constituents are Real Estate Investment Trusts (REITs), while one is a real estate developer. Given the significant Real Estate weighting – with majority of the constituents being REITs – the Index maintains a relatively high dividend yield of 3.8%, almost on par with the benchmark Straits Times Index’s (STI) yield of around 4.0%.

The table below details the 10 largest constituents of the FTSE ST Small Cap Index, sorted by market capitalisation. Click on the stock name to view its profile in StockFacts.

Name
SGX
Code
Index
Weight
%
Market
Cap
S$M
11 July
Closing
Price
Total
Returns
YTD %
Total
Returns
1Y %
Total
Returns
3Y %
P/E
(x)
Dvd Ind
Yld %

Tianjin Zhongxin Pharma
T14
1.3
2,669
1.070
20.1
14.2
-8.3
9.9
2.8

Frasers Logistics & Industrial
BUOU
5.3
2,127
1.060
-5.9
6.5
N/A
14.7
6.2

Thomson Medical Group
A50
2.1
2,008
0.077
-39.5
16.7
-49.3
N/A
N/A

Keppel DC REIT
AJBU
4.8
1,851
1.370
-1.3
15.0
60.9
22.5
5.2

Sheng Siong Group
OV8
2.0
1,609
1.070
16.6
12.3
43.0
22.7
3.1

Manulife US REIT*
BTOU
5.7
1,479
0.855
0.6
5.0
N/A
12.5
6.8

Cromwell European REIT*
CNNU
1.7
1,467
0.585
7.0
N/A
N/A
N/A
N/A

Bukit Sembawang Estates
B61
4.3
1,375
5.310
-7.2
-14.9
21.4
25.4
0.8

China Aviation Oil Singapore
G92
1.6
1,263
1.460
-4.8
-10.6
111.4
10.4
3.1

Frasers Hospitality Trust
ACV
2.2
1,280
0.685
-10.5
0.2
10.2
8.1
7.2

Source: Bloomberg & SGX StockFacts (data as of 11 July 2018)
* Note: Tianjin Zhongxin Pharmaceutical and Manulife US REIT are traded in USD, while Cromwell European REIT is traded in EUR; their SGD equivalents are shown in the table.

In the 2018 year-to-date, the five best-performing constituents of the Index were: China Sunsine Chemical (+69.4%), BreadTalk (+40.9%), Japfa (+27.8%), Tianjin Zhongxin Pharmaceutical (+20.1%), and HRnetGroup (+19.1%). These five constituents – from the Materials, Consumer and Healthcare sectors – have averaged a +35.5% total return in the YTD. This brings their average 12-month total return to +28.6%.

The table below details the five best-performing constituents of the FTSE ST Small Cap Index, sorted by YTD total returns. Click on the stock name to view its profile in StockFacts.

Name
SGX
Code
Index
Weight
%
Market
Cap
S$M
11 July
Closing
Price
Total
Returns
YTD %
Total
Returns
1Y %
Total
Returns
3Y %
P/E
(x)
Dvd Ind
Yld %

China Sunsine Chemical
CH8
0.9
649
1.320
69.4
68.7
288.1
6.9
2.3

BreadTalk Group
CTN
1.3
648
1.150
40.9
56.5
77.8
54.2
1.7

Japfa
UD2
1.0
1,237
0.670
27.8
2.6
89.8
55.9
0.8

Tianjin Zhongxin Pharma
T14
1.3
2,669
1.070
20.1
14.2
-8.3
9.9
2.8

HRnetGroup
CHZ
0.8
862
0.855
19.1
1.2
N/A
16.3
2.7

 
  
 
 
35.5
28.6
32.0
  

 

Source: Bloomberg & SGX StockFacts (data as of 11 July 2018)
* Note: Tianjin Zhongxin Pharmaceutical is traded in USD; its SGD equivalents are shown in table.

Over the same period, the five least-performing constituents of the Index were: Indofood Agri Resources (-42.3%), Thomson Medical Group (-39.5%), Courts Asia (-36.9%), Hi-P International (-36.2%), and Yoma Strategic (-33.3%). These five constituents – from the Healthcare, Consumer, Real Estate and Information Technology sectors – have averaged a -37.7% total return in the YTD, bringing their average 12-month total return to -13.3%.

This article is provided by SGX My Gateway.

SGX My Gateway

SGX’s investor education portal with market, product and investment information and events. Sign up now at sgx.com/mygateway to receive our investment updates and economic calendar.

This document is not intended for distribution to, or for use by or to be acted on by any person or entity located in any jurisdiction where such distribution, use or action would be contrary to applicable laws or regulations or would subject Singapore Exchange Limited (“SGX”) to any registration or licensing requirement. This document is not an offer or solicitation to buy or sell, nor financial advice or recommendation for any investment product. This document is for general circulation only. It does not address the specific investment objectives, financial situation or particular needs of any person. Advice should be sought from a financial adviser regarding the suitability of any investment product before investing or adopting any investment strategies. Use of and/or reliance on this document is entirely at the reader’s own risk. Further information on this investment product may be obtained from www.sgx.com. Investment products are subject to significant investment risks, including the possible loss of the principal amount invested. Past performance of investment products is not indicative of their future performance. Examples provided are for illustrative purposes only. While each of SGX and its affiliates (collectively, the “SGX Group Companies”) have taken reasonable care to ensure the accuracy and completeness of the information provided, each of the SGX Group Companies disclaims any and all guarantees, representations and warranties, expressed or implied, in relation to this document and shall not be responsible or liable (whether under contract, tort (including negligence) or otherwise) for any loss or damage of any kind (whether direct, indirect or consequential losses or other economic loss of any kind, including without limitation loss of profit, loss of reputation and loss of opportunity) suffered or incurred by any person due to any omission, error, inaccuracy, incompleteness, or otherwise, any reliance on such information, or arising from and/or in connection with this document. The information in this document may have been obtained via third party sources and which have not been independently verified by any SGX Group Company. No SGX Group Company endorses or shall be liable for the content of information provided by third parties. The SGX Group Companies may deal in investment products in the usual course of their business, and may be on the opposite side of any trades. SGX is an exempt financial adviser under the Financial Advisers Act (Cap. 110) of Singapore. The information in this document is subject to change without notice. This document shall not be reproduced, republished, uploaded, linked, posted, transmitted, adapted, copied, translated, modified, edited or otherwise displayed or distributed in any manner without SGX’s prior written consent.

More Info: sginvestors.io

Leave a Reply